American International Group, Inc. Macrogenics Inc Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$9.77 - $21.47 $2,520 - $5,539	-258 Reduced 0.85%	29,993 $441,000
Q4 2023 Feb 13, 2024	SELL	$4.48 - $10.11 $546 - $1,233	-122 Reduced 0.4%	30,251 $291,000
Q3 2023 Nov 13, 2023	BUY	$4.48 - $6.19 $4,838 - $6,685	1,080 Added 3.69%	30,373 $141,000
Q2 2023 Aug 04, 2023	BUY	$4.62 - $7.54 $924 - $1,508	200 Added 0.69%	29,293 $156,000
Q1 2023 May 12, 2023	BUY	$4.82 - $7.24 $2,790 - $4,191	579 Added 2.03%	29,093 $208,000
Q4 2022 Feb 10, 2023	SELL	$3.34 - $6.98 $344 - $718	-103 Reduced 0.36%	28,514 $191,000
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $1,213 - $2,103	403 Added 1.43%	28,617 $99,000
Q2 2022 Aug 12, 2022	SELL	$2.25 - $9.99 $3,591 - $15,944	-1,596 Reduced 5.35%	28,214 $83,000
Q1 2022 May 13, 2022	SELL	$8.12 - $16.9 $17,043 - $35,473	-2,099 Reduced 6.58%	29,810 $263,000
Q4 2021 Feb 11, 2022	SELL	$15.91 - $21.88 $15,178 - $20,873	-954 Reduced 2.9%	31,909 $512,000
Q3 2021 Nov 12, 2021	SELL	$19.74 - $28.7 $3,770 - $5,481	-191 Reduced 0.58%	32,863 $688,000
Q2 2021 Aug 13, 2021	BUY	$20.49 - $35.63 $22,477 - $39,086	1,097 Added 3.43%	33,054 $888,000
Q1 2021 May 07, 2021	BUY	$18.99 - $33.2 $1,595 - $2,788	84 Added 0.26%	31,957 $1.02 Million
Q4 2020 Feb 12, 2021	BUY	$19.41 - $26.0 $5,881 - $7,878	303 Added 0.96%	31,873 $729,000
Q3 2020 Nov 04, 2020	BUY	$24.69 - $31.6 $55,626 - $71,194	2,253 Added 7.68%	31,570 $795,000
Q2 2020 Aug 12, 2020	BUY	$5.2 - $29.12 $5,720 - $32,032	1,100 Added 3.9%	29,317 $819,000
Q1 2020 May 04, 2020	SELL	$4.28 - $12.11 $6,972 - $19,727	-1,629 Reduced 5.46%	28,217 $164,000
Q4 2019 Feb 05, 2020	SELL	$7.95 - $12.27 $1,995 - $3,079	-251 Reduced 0.83%	29,846 $325,000
Q3 2019 Nov 08, 2019	SELL	$12.44 - $17.48 $2,624 - $3,688	-211 Reduced 0.7%	30,097 $384,000
Q2 2019 Aug 13, 2019	BUY	$14.51 - $19.71 $77,048 - $104,660	5,310 Added 21.24%	30,308 $514,000
Q1 2019 May 06, 2019	SELL	$11.11 - $25.6 $9,010 - $20,761	-811 Reduced 3.14%	24,998 $449,000
Q4 2018 Feb 13, 2019	SELL	$11.75 - $21.42 $2,326 - $4,241	-198 Reduced 0.76%	25,809 $328,000
Q3 2018 Nov 09, 2018	BUY	$19.26 - $23.46 $9,032 - $11,002	469 Added 1.84%	26,007 $558,000
Q2 2018 Aug 08, 2018	BUY	$19.78 - $24.67 $76,489 - $95,398	3,867 Added 17.84%	25,538 $527,000
Q1 2018 May 07, 2018	SELL	$18.89 - $32.46 $22,006 - $37,815	-1,165 Reduced 5.1%	21,671 $545,000
Q4 2017 Feb 09, 2018	BUY	$16.19 - $20.3 $8,596 - $10,779	531 Added 2.38%	22,836 $434,000
Q3 2017 Nov 09, 2017	BUY	$15.52 - $18.94 $346,173 - $422,456	22,305	22,305 $412,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$32.4 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.4 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.5 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account